TechFinancials Inc. - Dual Quote on NEX Exchange Growth Market and AIM
RNS Number : 2281X
TechFinancials Inc.
08 August 2018
 

 

                                                                                                                          8 August 2018

 

TechFinancials, Inc.

                               ("TechFinancials, Inc." or "the Company")                                      

    Dual Quote on NEX Exchange Growth Market and AIM 

TechFinancials, Inc. the AIM quoted, fintech software provider of financial solutions including blockchain-based digital assets and traditional financial trading solutions for retail clients, is pleased to announce that trading of its of 84,980,979 fully paid ordinary shares of USD0.0005 ("Ordinary Shares") has commenced on the NEX Growth Market today ("Admission"). The Company sees its plan to dual list its Ordinary Shares on NEX as being entirely complementary to its AIM listing and the Company plans to remain trading on AIM following Admission.

 

--ENDS--

 

For further information, please contact:

 

 TechFinancials, Inc.

 

 Asaf Lahav, Group Chief Executive Officer

         +972 54 5233 943

 

 Yuval Tovias, Chief Financial Officer

  https://techfinancials.com/

 

 

 

  NEX Corporate Adviser and Joint Broker

  Peterhouse Capital Limited

 

  Fungai Ndoro / Eran Zucker

   +44 (0) 20 7469 0930

 

Grant Thornton UK LLP (Nominated Adviser)

 

 

Colin Aaronson / Samantha Harrison / Seamus Fricker

  +44 (0) 20 7383 5100

 

           

 

   Northland Capital Partners Limited ( Joint Broker)

 

   David Hignell / Rob Rees

   +44 (0) 20 3861 6625

 

   Media enquiries:

 

   Yellow Jersey (Media Relations)

 

   Charles Goodwin / Katie Bairsto

   +44 (0) 7748 843 871

 


This information is provided by RNS, the news service of the . RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCZMGGRZRVGRZM ]]>